Alerts will be sent to your verified email
Verify EmailACCENTMIC
|
Accent Microcell
|
Beta Drugs
|
Bajaj Healthcare
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
19.21 % | 22.74 % | 14.81 % |
|
5yr average Equity Multiplier
|
2.16 | 1.82 | 2.22 |
|
5yr Average Asset Turnover Ratio
|
1.47 | 1.03 | 0.84 |
|
5yr Avg Net Profit Margin
|
7.63 % | 12.23 % | 3.88 % |
|
Price to Book
|
0.0 | 0.0 | 1.86 |
|
P/E
|
26.06 | 25.18 | 46.66 |
|
5yr Avg Cash Conversion Cycle
|
85.19 Days | 7.75 Days | 130.36 Days |
|
Inventory Days
|
68.46 Days | 46.07 Days | 89.93 Days |
|
Days Receivable
|
81.86 Days | 91.57 Days | 145.27 Days |
|
Days Payable
|
72.23 Days | 119.03 Days | 94.44 Days |
|
5yr Average Interest Coverage Ratio
|
34.73 | 14.42 | 6.35 |
|
5yr Avg ROCE
|
24.49 % | 27.84 % | 22.78 % |
|
5yr Avg Operating Profit Margin
|
11.48 % | 21.76 % | 17.36 % |
|
5 yr average Debt to Equity
|
0.49 | 0.29 | 0.86 |
|
5yr CAGR Net Profit
|
47.1 % | 29.34 % | -13.82 % |
|
5yr Average Return on Assets
|
10.07 % | 12.69 % | 4.81 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
55.47 % | 64.63 % | 58.29 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.38 % | -2.1 % | -9.2 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 1.69 % |
|
Accent Microcell
|
Beta Drugs
|
Bajaj Healthcare
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|